| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2887816 | Annals of Vascular Surgery | 2010 | 6 Pages |
Abstract
CAS is feasible and safe in treating CR. Furthermore, midterm overall survival and need for treatment of re-recurrence is equal to CEA. However, reoperation is an established option and remains the treatment of choice when contraindications for CAS are evident.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Nicolas Attigah, Sonja Külkens, Claudia Deyle, Peter Ringleb, Marius Hartmann, Philipp Geisbüsch, Dittmar Böckler,